annual FCF:
$77.41M+$81.68M(+1911.96%)Summary
- As of today (May 24, 2025), LGND annual free cash flow is $77.41 million, with the most recent change of +$81.68 million (+1911.96%) on December 31, 2024.
- During the last 3 years, LGND annual FCF has risen by +$7.37 million (+10.52%).
- LGND annual FCF is now -57.74% below its all-time high of $183.17 million, reached on December 31, 2018.
Performance
LGND Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$27.48M-$55.24M(-198.99%)Summary
- As of today (May 24, 2025), LGND quarterly free cash flow is -$27.48 million, with the most recent change of -$55.24 million (-198.99%) on March 31, 2025.
- Over the past year, LGND quarterly FCF has dropped by -$43.66 million (-269.80%).
- LGND quarterly FCF is now -137.31% below its all-time high of $73.64 million, reached on June 30, 2018.
Performance
LGND quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$33.74M-$43.66M(-56.41%)Summary
- As of today (May 24, 2025), LGND TTM free cash flow is $33.74 million, with the most recent change of -$43.66 million (-56.41%) on March 31, 2025.
- Over the past year, LGND TTM FCF has increased by +$53.37 million (+271.97%).
- LGND TTM FCF is now -82.61% below its all-time high of $194.06 million, reached on December 31, 2018.
Performance
LGND TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
LGND Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1912.0% | -269.8% | +272.0% |
| 3 y3 years | +10.5% | -158.3% | -69.3% |
| 5 y5 years | +342.7% | -262.4% | +158.5% |
LGND Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -35.5% | +1912.0% | -152.5% | +35.6% | -71.9% | +272.0% |
| 5 y | 5-year | -35.5% | +342.7% | -152.5% | +35.6% | -71.9% | +158.5% |
| alltime | all time | -57.7% | +155.2% | -137.3% | +76.7% | -82.6% | +117.9% |
LGND Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$27.48M(-199.0%) | $33.74M(-56.4%) |
| Dec 2024 | $77.41M(-1912.0%) | $27.76M(+24.5%) | $77.41M(+1010.9%) |
| Sep 2024 | - | $22.29M(+99.5%) | $6.97M(-185.4%) |
| Jun 2024 | - | $11.18M(-31.0%) | -$8.16M(-58.4%) |
| Mar 2024 | - | $16.18M(-137.9%) | -$19.62M(+359.3%) |
| Dec 2023 | -$4.27M(-103.6%) | -$42.68M(-696.2%) | -$4.27M(-104.7%) |
| Sep 2023 | - | $7.16M(-2611.9%) | $90.71M(-8.1%) |
| Jun 2023 | - | -$285.00K(-100.9%) | $98.75M(-5.3%) |
| Mar 2023 | - | $31.53M(-39.7%) | $104.33M(-13.0%) |
| Dec 2022 | $119.93M(+71.2%) | $52.30M(+244.1%) | $119.93M(+28.9%) |
| Sep 2022 | - | $15.20M(+187.3%) | $93.07M(-3.2%) |
| Jun 2022 | - | $5.29M(-88.8%) | $96.13M(-12.5%) |
| Mar 2022 | - | $47.14M(+85.2%) | $109.82M(+56.8%) |
| Dec 2021 | $70.04M(+39.7%) | $25.45M(+39.4%) | $70.04M(+61.0%) |
| Sep 2021 | - | $18.25M(-3.9%) | $43.50M(+21.0%) |
| Jun 2021 | - | $18.99M(+158.3%) | $35.95M(-11.4%) |
| Mar 2021 | - | $7.35M(-772.5%) | $40.56M(-19.1%) |
| Dec 2020 | $50.13M(-257.2%) | -$1.09M(-110.2%) | $50.13M(+14.2%) |
| Sep 2020 | - | $10.71M(-54.6%) | $43.88M(+62.7%) |
| Jun 2020 | - | $23.59M(+39.4%) | $26.98M(-146.8%) |
| Mar 2020 | - | $16.92M(-330.6%) | -$57.67M(+96.6%) |
| Dec 2019 | -$31.89M(-117.4%) | -$7.34M(+18.4%) | -$29.34M(-377.4%) |
| Sep 2019 | - | -$6.20M(-89.9%) | $10.57M(-75.9%) |
| Jun 2019 | - | -$61.06M(-234.9%) | $43.85M(-75.4%) |
| Mar 2019 | - | $45.26M(+38.9%) | $178.56M(-8.0%) |
| Dec 2018 | $183.17M(+112.0%) | $32.57M(+20.3%) | $194.06M(+0.7%) |
| Sep 2018 | - | $27.08M(-63.2%) | $192.80M(-0.3%) |
| Jun 2018 | - | $73.64M(+21.2%) | $193.37M(+48.6%) |
| Mar 2018 | - | $60.76M(+94.1%) | $130.11M(+46.9%) |
| Dec 2017 | $86.41M(+109.8%) | $31.31M(+13.2%) | $88.57M(+6.7%) |
| Sep 2017 | - | $27.65M(+166.2%) | $82.97M(+15.8%) |
| Jun 2017 | - | $10.39M(-46.0%) | $71.66M(+35.3%) |
| Mar 2017 | - | $19.22M(-25.2%) | $52.98M(+28.6%) |
| Dec 2016 | $41.19M(+33.4%) | $25.71M(+57.4%) | $41.19M(+51.0%) |
| Sep 2016 | - | $16.34M(-297.0%) | $27.27M(+35.7%) |
| Jun 2016 | - | -$8.29M(-211.6%) | $20.10M(-40.8%) |
| Mar 2016 | - | $7.43M(-37.0%) | $33.97M(+10.1%) |
| Dec 2015 | $30.86M(+92.1%) | $11.80M(+28.8%) | $30.86M(+15.4%) |
| Sep 2015 | - | $9.16M(+64.1%) | $26.75M(+27.0%) |
| Jun 2015 | - | $5.58M(+29.2%) | $21.05M(+8.3%) |
| Mar 2015 | - | $4.32M(-43.7%) | $19.44M(+21.0%) |
| Dec 2014 | $16.07M(+2.0%) | $7.68M(+121.6%) | $16.07M(-17.2%) |
| Sep 2014 | - | $3.47M(-12.5%) | $19.41M(+26.2%) |
| Jun 2014 | - | $3.96M(+315.9%) | $15.38M(+4.9%) |
| Mar 2014 | - | $953.00K(-91.4%) | $14.66M(-6.9%) |
| Dec 2013 | $15.75M(-285.7%) | $11.03M(-2055.9%) | $15.75M(+127.3%) |
| Sep 2013 | - | -$564.00K(-117.4%) | $6.93M(+155.4%) |
| Jun 2013 | - | $3.25M(+59.0%) | $2.71M(-280.3%) |
| Mar 2013 | - | $2.04M(-7.6%) | -$1.50M(-82.3%) |
| Dec 2012 | -$8.48M(+105.6%) | $2.21M(-146.2%) | -$8.48M(+30.2%) |
| Sep 2012 | - | -$4.78M(+391.0%) | -$6.51M(+124.8%) |
| Jun 2012 | - | -$974.00K(-80.3%) | -$2.90M(-70.9%) |
| Mar 2012 | - | -$4.94M(-218.1%) | -$9.97M(+141.6%) |
| Dec 2011 | -$4.13M(-85.5%) | $4.18M(-458.5%) | -$4.13M(-56.5%) |
| Sep 2011 | - | -$1.17M(-85.5%) | -$9.48M(-40.7%) |
| Jun 2011 | - | -$8.04M(-988.0%) | -$15.99M(+38.5%) |
| Mar 2011 | - | $906.00K(-177.3%) | -$11.55M(-59.3%) |
| Dec 2010 | -$28.38M(-17.3%) | -$1.17M(-84.7%) | -$28.38M(-0.4%) |
| Sep 2010 | - | -$7.68M(+113.2%) | -$28.49M(-12.0%) |
| Jun 2010 | - | -$3.60M(-77.4%) | -$32.37M(+24.9%) |
| Mar 2010 | - | -$15.93M(+1150.5%) | -$25.92M(-24.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$34.32M(+62.5%) | -$1.27M(-89.0%) | -$34.32M(+27.6%) |
| Sep 2009 | - | -$11.56M(-506.4%) | -$26.90M(-6.8%) |
| Jun 2009 | - | $2.84M(-111.7%) | -$28.86M(-19.5%) |
| Mar 2009 | - | -$24.34M(-495.6%) | -$35.86M(+69.8%) |
| Dec 2008 | -$21.12M(-78.5%) | $6.15M(-145.5%) | -$21.12M(-41.5%) |
| Sep 2008 | - | -$13.52M(+224.9%) | -$36.13M(-2.0%) |
| Jun 2008 | - | -$4.16M(-56.6%) | -$36.88M(-40.8%) |
| Mar 2008 | - | -$9.60M(+8.3%) | -$62.33M(-36.5%) |
| Dec 2007 | -$98.17M(-30.0%) | -$8.86M(-37.9%) | -$98.17M(-43.4%) |
| Sep 2007 | - | -$14.27M(-51.8%) | -$173.57M(-7.8%) |
| Jun 2007 | - | -$29.61M(-34.8%) | -$188.24M(+13.7%) |
| Mar 2007 | - | -$45.44M(-46.1%) | -$165.56M(+18.0%) |
| Dec 2006 | -$140.30M(+415.2%) | -$84.26M(+191.2%) | -$140.30M(+217.1%) |
| Sep 2006 | - | -$28.94M(+317.5%) | -$44.24M(+3.6%) |
| Jun 2006 | - | -$6.93M(-65.6%) | -$42.69M(-3.4%) |
| Mar 2006 | - | -$20.17M(-270.9%) | -$44.21M(+62.4%) |
| Dec 2005 | -$27.23M(-1366.6%) | $11.80M(-143.1%) | -$27.23M(+156.3%) |
| Sep 2005 | - | -$27.39M(+224.0%) | -$10.62M(-219.3%) |
| Jun 2005 | - | -$8.45M(+164.7%) | $8.90M(+91.8%) |
| Mar 2005 | - | -$3.19M(-111.2%) | $4.64M(+115.9%) |
| Dec 2004 | $2.15M(-132.6%) | $28.41M(-461.4%) | $2.15M(-109.5%) |
| Sep 2004 | - | -$7.86M(-38.2%) | -$22.72M(+24.4%) |
| Jun 2004 | - | -$12.71M(+123.7%) | -$18.27M(+693.2%) |
| Mar 2004 | - | -$5.68M(-260.6%) | -$2.30M(-65.1%) |
| Dec 2003 | -$6.60M(-95.2%) | $3.54M(-203.9%) | -$6.60M(-94.8%) |
| Sep 2003 | - | -$3.41M(-204.9%) | -$128.07M(-0.6%) |
| Jun 2003 | - | $3.25M(-132.5%) | -$128.90M(-10.9%) |
| Mar 2003 | - | -$9.98M(-91.5%) | -$144.70M(+6.1%) |
| Dec 2002 | -$136.35M(+523.2%) | -$117.92M(+2684.5%) | -$136.35M(+510.3%) |
| Sep 2002 | - | -$4.24M(-66.3%) | -$22.34M(-11.5%) |
| Jun 2002 | - | -$12.56M(+667.7%) | -$25.26M(+165.5%) |
| Mar 2002 | - | -$1.64M(-58.2%) | -$9.51M(-56.5%) |
| Dec 2001 | -$21.88M(-52.7%) | -$3.91M(-45.2%) | -$21.88M(-17.3%) |
| Sep 2001 | - | -$7.15M(-324.3%) | -$26.46M(-21.3%) |
| Jun 2001 | - | $3.19M(-122.7%) | -$33.64M(-27.0%) |
| Mar 2001 | - | -$14.01M(+64.8%) | -$46.12M(-0.4%) |
| Dec 2000 | -$46.30M(-25.4%) | -$8.50M(-40.7%) | -$46.30M(-2.5%) |
| Sep 2000 | - | -$14.33M(+54.3%) | -$47.50M(-1.2%) |
| Jun 2000 | - | -$9.29M(-34.6%) | -$48.08M(-10.6%) |
| Mar 2000 | - | -$14.19M(+46.3%) | -$53.79M(-13.4%) |
| Dec 1999 | -$62.10M(-10.0%) | -$9.70M(-34.9%) | -$62.10M(-11.5%) |
| Sep 1999 | - | -$14.90M(-0.7%) | -$70.20M(-2.4%) |
| Jun 1999 | - | -$15.00M(-33.3%) | -$71.90M(+1.8%) |
| Mar 1999 | - | -$22.50M(+26.4%) | -$70.60M(+2.3%) |
| Dec 1998 | -$69.00M(+289.8%) | -$17.80M(+7.2%) | -$69.00M(+77.8%) |
| Sep 1998 | - | -$16.60M(+21.2%) | -$38.80M(+19.0%) |
| Jun 1998 | - | -$13.70M(-34.4%) | -$32.60M(+7.6%) |
| Mar 1998 | - | -$20.90M(-268.5%) | -$30.30M(+71.2%) |
| Dec 1997 | -$17.70M(-47.5%) | $12.40M(-219.2%) | -$17.70M(-51.2%) |
| Sep 1997 | - | -$10.40M(-8.8%) | -$36.30M(+0.6%) |
| Jun 1997 | - | -$11.40M(+37.3%) | -$36.10M(+8.1%) |
| Mar 1997 | - | -$8.30M(+33.9%) | -$33.40M(-0.9%) |
| Dec 1996 | -$33.70M(-11.5%) | -$6.20M(-39.2%) | -$33.70M(+22.5%) |
| Sep 1996 | - | -$10.20M(+17.2%) | -$27.50M(+59.0%) |
| Jun 1996 | - | -$8.70M(+1.2%) | -$17.30M(+101.2%) |
| Mar 1996 | - | -$8.60M(+168.8%) | -$8.60M(-43.0%) |
| Dec 1995 | -$38.10M(+155.7%) | - | - |
| Mar 1995 | - | -$3.20M(-28.9%) | -$15.10M(+1.3%) |
| Dec 1994 | -$14.90M | -$4.50M(+45.2%) | -$14.90M(+43.3%) |
| Sep 1994 | - | -$3.10M(-27.9%) | -$10.40M(+42.5%) |
| Jun 1994 | - | -$4.30M(+43.3%) | -$7.30M(+143.3%) |
| Mar 1994 | - | -$3.00M | -$3.00M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual free cash flow?
- What is the all time high annual FCF for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual FCF year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly free cash flow?
- What is the all time high quarterly FCF for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly FCF year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM free cash flow?
- What is the all time high TTM FCF for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM FCF year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual free cash flow?
The current annual FCF of LGND is $77.41M
What is the all time high annual FCF for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual free cash flow is $183.17M
What is Ligand Pharmaceuticals Incorporated annual FCF year-on-year change?
Over the past year, LGND annual free cash flow has changed by +$81.68M (+1911.96%)
What is Ligand Pharmaceuticals Incorporated quarterly free cash flow?
The current quarterly FCF of LGND is -$27.48M
What is the all time high quarterly FCF for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly free cash flow is $73.64M
What is Ligand Pharmaceuticals Incorporated quarterly FCF year-on-year change?
Over the past year, LGND quarterly free cash flow has changed by -$43.66M (-269.80%)
What is Ligand Pharmaceuticals Incorporated TTM free cash flow?
The current TTM FCF of LGND is $33.74M
What is the all time high TTM FCF for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM free cash flow is $194.06M
What is Ligand Pharmaceuticals Incorporated TTM FCF year-on-year change?
Over the past year, LGND TTM free cash flow has changed by +$53.37M (+271.97%)